Cited by 74Palliative Care and End-of-Life IssuesPalliative and Oncologic CareEmpathy and Medical Education

Medicine’s Uncomfortable Relationship With Math: Calculating Positive Predictive Value

Open access
Manrai, Arjun K., Bhatia, Gaurav, Strymish, Judith, Kohane, Isaac S., Jain, Sachin H.·2014·JAMA Internal Medicine

Abstract

of the patients who died with a diagnosis of hematologic malignant neoplasm had received treatment within 14 days of the end of life, indicating a major difference in treatment practice for these disorders compared with solid tumors.Communication with patients about realistic prognosis, treatment planning, and advanced care planning is a critical component across the continuum of oncology care. 5 A recent report issued by the Institute of Medicine specifically emphasizes that "[p]atients with advanced cancer should receive end-of-life care consistent with their needs, values, and preferences." 6 We hope that analysis and reporting of observed practice patterns and disease outcomes will drive discussions between physicians and patients that address realistic concerns and the patient's values around end-of-life care.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1001/jamainternmed.2014.1059

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The PPV and NPV estimates from the study should not be extrapolated to other clinical settings where the prevalence of AD is substantially different.

    “Correspondingly, the PPV and NPV estimates from our study should not be extrapolated to other clinical settings where the prevalence of AD is substantially different11,12,14,15.”

    From Diagnosis of Alzheimer's disease using plasma biomarkers adjusted to clinical probability (2024) · cites this paper as [14]

    The Results and Discussion explain that PPV depends on disease prevalence, supporting caution about applying a PPV estimate where prevalence differs. The paper does not discuss NPV, AD, or estimates from the citing authors’ study, so it does not support those parts of the claim. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • Predictive values are critical for interpreting individual-level test results.

    “In contrast, predictive values are critical for interpreting individual-level test results11,12,14,15.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 4 · Cited by 74

Research works printed but not linked: 1

  1. [4]Association of American Medical Colleges MR5: 5th Comprehensive Review of the Medical College Admission Test® (MCAT®) https://www.aamc.org/initiatives/mr5/. Accessed October 9, 2013

Authors
Manrai, A. K., Bhatia, G., Strymish, J., Kohane, I. S., & Jain, S. H.
Affiliations
  • Harvard University (US)
  • Broad Institute (US)
  • Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
Venue
JAMA Internal Medicine
Published
2014-06-01
Volume
174
Issue
6
Pages
991
ISSN
2168-6106 (ISSN-L)
OpenAlex
W1999471281
Cited by
74
References
4
Citations by year
2026: 6 · 2025: 4 · 2024: 6 · 2023: 1 · 2022: 3 · 2021: 7 · 2020: 8 · 2019: 10 · 2018: 15 · 2017: 4 · 2016: 4 · 2015: 3 · 2014: 3
FWCI
4.62
Type
journal article
Language
en
Open access
Locations
  • JAMA Internal Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Human Genome Research Institute (T32HG002295)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Palliative Care and End-of-Life Issues
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Palliative and Oncologic Care
  • Health Sciences › Medicine › Psychiatry and Mental health › Empathy and Medical Education
Keywords
end-of-life care, hematologic malignancies, advanced cancer, prognosis communication, advance care planning, treatment patterns, patient preferences, cancer care
MeSH terms
False Positive Reactions, Humans, Predictive Value of Tests, Statistics as Topic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review